Miglustat for treatment of Niemann-Pick C disease: a randomised
Descrição
Correlation of age of onset and clinical severity in Niemann–Pick disease type C1 with lysosomal abnormalities and gene expression
Niemann- Pick Disease Type C (NPC) Market Report 2023-2033 - Wissen Research
PDF] Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study
Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression
Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann–Pick Type C Using Quantitative Proteomics
Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study - The Lancet Neurology
Tolerance of chronic HDACi treatment for neurological, visceral and lung Niemann-Pick Type C disease in mice
Psychiatric and Cognitive Symptoms Associated with Niemann-Pick Type C Disease: Neurobiology and Management
Imaging of neuroinflammation in adult Niemann-Pick type C disease
Influence of miglustat therapy on NP-C patient survival. Kaplan-Meier
Miglustat - LiverTox - NCBI Bookshelf
de
por adulto (o preço varia de acordo com o tamanho do grupo)
